These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15999505)

  • 21. The FDA prasugrel review: adjudication of myocardial infarction controversy.
    Serebruany VL
    Cardiology; 2009; 114(2):126-9. PubMed ID: 19506374
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl.
    Spencer FA; Goldberg RJ; Gore JM; Fox KA; Avezum A; Agnelli G; Kritharides L; Anderson FA; Goodman SG; FitzGerald G; Allegrone J; Brieger D;
    Am J Cardiol; 2007 Sep; 100(6):913-8. PubMed ID: 17826369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study.
    Reckless JP; Henry P; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO; Lis K; Brudi P; Allen C
    Int J Clin Pract; 2008 Apr; 62(4):539-54. PubMed ID: 18266852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of C-reactive protein and one-year survival after acute myocardial infarction with versus without statin therapy.
    Kinjo K; Sato H; Sakata Y; Nakatani D; Mizuno H; Shimizu M; Nishino M; Ito H; Tanouchi J; Nanto S; Hori M;
    Am J Cardiol; 2005 Sep; 96(5):617-21. PubMed ID: 16125481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chronic statin pretreatment on hospital outcome in patients with acute non-ST-elevation myocardial infarction.
    Bauer T; Böhm M; Zahn R; Jünger C; Koeth O; Gitt A; Bestehorn K; Senges J; Zeymer U;
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):132-6. PubMed ID: 19188836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Rifai N; Kirtane AJ; McCabe CH; Skene AM; Gibson CM; Ridker PM; Braunwald E;
    J Am Coll Cardiol; 2005 Oct; 46(8):1417-24. PubMed ID: 16226164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of early statin treatment at standard doses on long-term clinical outcomes in patients with acute myocardial infarction (the Heart Institute of Japan, Department of Cardiology Statin Evaluation Program).
    Nagashima M; Koyanagi R; Kasanuki H; Hagiwara N; Yamaguchi J; Atsuchi N; Honda T; Haze K; Sumiyoshi T; Urashima M; Ogawa H;
    Am J Cardiol; 2007 Jun; 99(11):1523-8. PubMed ID: 17531574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes.
    Lenderink T; Boersma E; Gitt AK; Zeymer U; Wallentin L; Van de Werf F; Hasdai D; Behar S; Simoons ML
    Eur Heart J; 2006 Aug; 27(15):1799-804. PubMed ID: 16820364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The intensive statin therapy myth.
    Shechter M; Beigel R; Matetzky S; Freimark D; Chouraqui P
    Isr Med Assoc J; 2005 Nov; 7(11):683-7. PubMed ID: 16308988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensive statin therapy in coronary artery disease: is lower cholesterol better and safe?
    Seshasai SR; Ray KK
    Future Cardiol; 2009 Mar; 5(2):129-39. PubMed ID: 19371188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial.
    Rouleau J
    Am J Med; 2005 Dec; 118 Suppl 12A():28-35. PubMed ID: 16356805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials).
    Brilakis ES; de Lemos JA; Cannon CP; Wiviott SD; Murphy SA; Morrow DA; Sabatine MS; Banerjee S; Blazing MA; Califf RM; Braunwald E
    Am J Cardiol; 2008 Sep; 102(5):552-8. PubMed ID: 18721511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can clopidogrel and aspirin lower mortality in patients with acute myocardial infarction?
    Bhatt DL
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):182-3. PubMed ID: 16568122
    [No Abstract]   [Full Text] [Related]  

  • 35. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.
    Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S
    Circulation; 2007 May; 115(18):2398-409. PubMed ID: 17452609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22).
    Ray KK; Morrow DA; Shui A; Rifai N; Cannon CP
    Am J Cardiol; 2006 Oct; 98(7):861-5. PubMed ID: 16996863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality.
    Fonarow GC; Wright RS; Spencer FA; Fredrick PD; Dong W; Every N; French WJ;
    Am J Cardiol; 2005 Sep; 96(5):611-6. PubMed ID: 16125480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
    Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ
    Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early time to benefit with intensive statin treatment: could it be the pleiotropic effects?
    Ray KK; Cannon CP
    Am J Cardiol; 2005 Sep; 96(5A):54F-60F. PubMed ID: 16126024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.